Financhill
Back

iSpecimen Quote, Financials, Valuation and Earnings

iSpecimen Price Quote

$4.34
+0.03 (+0.7%)
(Updated: November 14, 2024 at 5:00 PM ET)

iSpecimen Key Stats

Sell
36
iSpecimen (ISPC) is a Sell

Day range:
$4.25 - $4.83
52-week range:
$3.41 - $12.80
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.21
P/B ratio:
0.48%

Volume:
206.1K
Avg. volume:
654.6K
1-year change:
-60.82%
Market cap:
$2.9M
Revenue:
$9.9M
EPS:
$-21.6

How Much Does iSpecimen Make?

  • How Much Are iSpecimen's Sales Annually?
    ISPC Revenues are $9.9M
  • How Much Profit Does iSpecimen's Make A Year?
    ISPC net income is -$11.1M

Is iSpecimen Growing As A Company?

  • What Is iSpecimen's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.76%
  • What Is iSpecimen's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

iSpecimen Stock Price Performance

  • Did iSpecimen Stock Go Up Last Month?
    iSpecimen share price went up by 1.65% last month
  • Did ISPC's Share Price Rise Over The Last Year?
    ISPC share price fell by -60.82% over the past 1 year

What Is iSpecimen 52-Week High & Low?

  • What Is iSpecimen’s 52-Week High Share Price?
    iSpecimen has traded as high as $12.80 over the past 52 weeks
  • What Is iSpecimen’s 52-Week Low Share Price?
    iSpecimen has traded as low as $3.41 over the past 52 weeks

iSpecimen Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy iSpecimen?

  • How Much Debt Does iSpecimen Have?
    Total long term debt quarterly is $0
  • How Much Cash Does iSpecimen Have?
    Cash and short term investments quarterly total is $2.2M
  • What Is iSpecimen’s Book Value Per Share?
    Book value per share is 9.30

Is iSpecimen Cash Flow Positive?

  • What Is ISPC Cash Flow From Operations?
    Cash flow from operations (TTM) is -$4.9M
  • What Is iSpecimen’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $1.2M
  • What Is iSpecimen’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $3.9M

iSpecimen Return On Invested Capital

  • Is Management Doing A Good Job?
    ISPC return on invested capital is -101.83%
  • What Is iSpecimen Return On Assets?
    ROA measures how assets are converting to revenues and is -68.79%
  • What Is ISPC Return On Equity?
    ROE is a measure of profitability and is -101.83%

iSpecimen Earnings Date & Stock Price

  • What Is iSpecimen's Stock Price Today?
    A single share of ISPC can be purchased today for 4.31
  • What Is iSpecimen’s Stock Symbol?
    iSpecimen trades on the nasdaq under the ticker symbol: ISPC
  • When Is iSpecimen’s Next Earnings Date?
    The next quarterly earnings date for iSpecimen is scheduled on November 14, 2024
  • When Is ISPC's next ex-dividend date?
    iSpecimen's next ex-dividend date is November 14, 2024
  • How To Buy iSpecimen Stock?
    You can buy iSpecimen shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

iSpecimen Competitors

  • Who Are iSpecimen's Competitors?
    Below is a list of companies who compete with iSpecimen or are related in some way:
    • CytoSorbents Corp (CTSO)
    • Delcath Systems Inc (DCTH)
    • 23andMe Holding Co (ME)
    • Progyny Inc (PGNY)
    • RadNet Inc (RDNT)

iSpecimen Dividend Yield

  • What Is ISPC Dividend Yield?
    iSpecimen’s dividend yield currently is 0%
  • What Is iSpecimen’s Payout Ratio?
    iSpecimen’s payout ratio is 0%
  • When Did iSpecimen Last Pay A Dividend?
    The latest dividend pay date is November 14, 2024
  • What Is iSpecimen’s Dividend Per Share?
    iSpecimen pays a dividend of $0.00 per share

iSpecimen Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 76.21% -0.6%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 60.00
Upside from Last Price: 1292.11%

Major Shareholders

  • How many ISPC shares are owned by institutional investors?
    294.9K ISPC shares are owned by institutional investors
  • How many ISPC shares are owned by insiders?
    0 ISPC shares are owned by insiders